- I am Connie Dello Buono, health author and blogger at www.careme.live ( soon http://www.avatarcare.net )
Since 2000, I have cared for seniors with cancer, Alzheimer’s and Parkinsons.
My passion is help reduce chronic care costs, health education and personalize medicine using telemedicine.
- This campaign will address cancer health issues, identifying root causes early, connecting with doctors real time, access to telemedicine and tele-clinics, matching providers using mobile application and a health application that will hep reduce chronic care costs.
- As contributors, you will help achieve our goal of reducing chronic care costs thru telemedicine, personalize medicine and a health mobile application serving all population groups.
- Maddalena Adorno PhD, CTO. She is a professor at Stanford University Institute for Stem Cells and Regenerative Medicine
- Connie Dello Buono, CEO. She is a health author and completed her B.S in Mathematics with minor in Chemistry at Adamson University, Manila Philippines
What We Need & What You Get
- $5000 of the funds will go to the mobile application developers and marketers.
- Your unique perks will be a lifetime discount, 20%, in the many health apps that will come out of this first phase of the product.
- Avatarcare.net or Motherhealth aims to help health consumers navigate in their health issues and collaborations with health care professionals by providing a platform for them to order their genetic and lab tests, join in health care forums, learn about health care issues and prevention, set up appointment with others and health care teams, find and post health care jobs, video chats with doctors and a health concierge provided online and in the future, via a mobile application.
- Globally, we can now correlate health data and provide valuable insights to all, scientists and the population.
- Since 2000, I have been educating the public on health, wrote an ebook on women’s health, was pharmacy tech instructor, a senior care administrator and care provider, and quality assurance in many biotech and medical device companies in the USA.
Blood Cancer (BC) Risk Factor
1.0 = 0.2 + 0.2 + 0.1 + 0.2 + 0.1 + 0.1 + 0.1
©Connie Dello Buono 15Sept2016
- Sex M=0.2 , F = 0.1
- Age > 15 yrs = 0.2 , < 15 yrs =0.1
- Race = 0.1 (South Asian, Caucasian)
- Prenatal exposure to x-rays/chemicals/alcohol ; = 0.2
- Environmental toxins, therapeutic radiation ; previous cancer treatment: Certain types of chemotherapy and radiation therapy for other cancers are considered leukemia risk factors ; smoking ; Diabetes 0.1
- Specific genetic syndromes ; Down syndrome ; 0.1
- Virus = 0.1
BC Risk Factor =1.0 (High) ; BC Risk Factor =
Please email your entries to email@example.com to create a database and get health data insights about Alzheimer’s disease
Modified Blood Risk Factor
Male = 0.2
|Age > 15yrs=0.2
15yrs <= 0.1
|Race = 0.1 (south asian)
|Prenatal exposure to x-rays, chemicals, medications/drugs, alcohol = 0.2
||Environmental toxins, therapeutic radiation , non-ionizing radiation,; previous cancer treatment: Certain types of chemotherapy and radiation therapy for other
|Metabolic and diet:
|smoking = 0.1
||Specific genetic syndromes ; Down syndrome = 0.1
Polymorphic alleles of the human leukocyte antigen (HLA) class II genes = 0.1
|Weak immune and metabolic system:
Infection and allergy 0.1
Prenatal health of mother may contribute to childhood leukemia
Prenatal exposure to x-rays, and genetic syndromes chromosomal alterations and mutations that disrupt the normal process by which lymphoid or myeloid progenitor cells differentiate and senesce. The underlying triggers for molecular damage may be inherited during pregnancy and may develop during infancy and childhood. These translocations are a ‘‘hallmark’’ genetic event in leukemia. Many leukemia patients have a chromosomal translocation that is often the only observable cytogenetic aberration. These abnormalities help categorize leukemia for treatment strategy and prognosis and may also delineate specific causal pathways to malignancy.
Recently, genetic backtracking analyses, using archived newborn blood specimens and pretreatment bone marrow or peripheral blood specimens obtained at the time of diagnosis, have been applied to study the timing of various translocations. To date, a prenatal origin has been established for several chromosomal abnormalities.
This link points to environmental carcinogens as one of the causes of blood cancer – > http://superfund.berkeley.edu/pdf/28.pdf
Join 25,000 people in helping redefine health with health concierge and precision medicine.